Neuroendocrine Tumour of the Lung Recruiting Phase 2 Trials for Sirolimus (DB00877)

Also known as: Pulmonary Neuroendocrine Tumor / Neuroendocrine Neoplasm of Lung / Neuroendocrine Tumor of the Lung / Pulmonary Neuroendocrine Tumors / Neuroendocrine Tumors in Lung / Neuroendocrine neoplasm of lung (disorder)

IndicationStatusPhase
DBCOND0133412 (Neuroendocrine Tumour of the Lung)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05997056Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR InhibitorsTreatment